COMMONWEALTH CANCER CONSORTIUM INC

COMMONWEALTH CANCER CONSORTIUM INC

Cambridge, MA, US
501(c)3
EIN
85-1681659

COMMONWEALTH CANCER CONSORTIUM INC

Cambridge, MA, US
501(c)3
EIN
85-1681659

Overview

Sign up for

Est.

2020

Fiscal Year Start

Jan 1

Organization Type

Grantseeker
AI Summary
Was this helpful?

Commonwealth Cancer Consortium Inc, operating under the mission of Break Through Cancer, is dedicated to advancing translational research for difficult-to-treat cancers through collaboration with leading cancer research centers across the country. With an operating budget of $28.7 million and total revenue of $13.4 million for the filing year 2024, the organization is committed to addressing the unmet needs of patients facing complex cancer challenges. It does not rely on a single funder for 50% or more of its revenue, ensuring a diverse funding base to support its initiatives. For more information, visit https://breakthroughcancer.org.

Mission Statement

BREAK THROUGH CANCER IS A FOUNDATION DEDICATED TO SUPPORTING TRANSLATIONAL RESEARCH IN THE MOST DIFFICULT TO TREAT CANCERS. OUR PARTNER ORGANIZATIONS ARE AMONG THE TOP CANCER RESEARCH CENTERS AND TOGETHER, REPRESENT SOME OF THE MOST BRILLIANT, CREATIVE MINDS IN THE COUNTRY. WE BELIEVE BREAK THROUGH CANCER IS THE BEGINNING OF A SCIENTIFIC MOVEMENT THAT ACCEPTS NOTHING LESS THAN MULTI-INSTITUTIONAL COLLABORATION IN PATIENT CENTRIC CANCER RESEARCH. THE FOUNDATION WILL WORK CLOSELY WITH TEAMS OF SCIENTISTS, ENGINEERS, AND CLINICAL RESEARCHERS TO FOCUS ON DIAGNOSING, TREATING, AND IDEALLY CURING SOME OF THE MOST INTRACTABLE FORMS OF CANCER. WHILE MANY PATIENTS HAVE BENEFITED FROM ADVANCES IN RESEARCH AND TECHNOLOGY, THERE ARE FAR TOO MANY WHO HAVE BEEN LEFT BEHIND. THERE ARE TOO MANY CANCERS WHERE THE NEEDLE REMAINS UNMOVED. BREAK THROUGH CANCER IS COMMITTED TO MAKING HEADWAY IN THESE EXTREMELY COMPLEX, CHALLENGING DISEASES, AND COMMITTED TO FINDING HOPE FOR PATIENTS AND THEIR FAMILIES.
Revenues

$13.4M

Expenses

$28.7M

Net Income:
-$15.3M
Assets

$57M

Liabilities

$1.1M

Net Assets:
+$55.9M
Operating Budget

$28.7M

Operating Budget by Year

Due Diligence

Are you a grantmaker?
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
plg-image
plg-image
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Total No. of Grants

4

Median grant size
$255K
Largest grant received
$27.1M
T
Tyler Jacks
Board Member
D
David Jaffray
Board Member
J
John Sherman
Board Member

Frequently Asked Questions

What is COMMONWEALTH CANCER CONSORTIUM INC’s budget?
In 2024, COMMONWEALTH CANCER CONSORTIUM INC reported an annual operating budget of around $28.7 million. More detailed financial information is available to registered users.
Where does COMMONWEALTH CANCER CONSORTIUM INC operate?
COMMONWEALTH CANCER CONSORTIUM INC is headquartered in Cambridge, MA.
Who funded COMMONWEALTH CANCER CONSORTIUM INC recently?
In 2024, COMMONWEALTH CANCER CONSORTIUM INC received grants from COMMONWEALTH FOUNDATION FOR CANCER RESEARCH, ALK POSITIVE INC, and THE US CHARITABLE GIFT TRUST. More information on this organization’s funders is available to registered users.
What is the largest grant COMMONWEALTH CANCER CONSORTIUM INC received in 2024?
The largest grant to COMMONWEALTH CANCER CONSORTIUM INC in 2024 exceeds $27.1 million.
Overview
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)